We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-20.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.64B
AUM Growth
+$440M
Cap. Flow
+$940M
Cap. Flow %
57.18%
Top 10 Hldgs %
44.47%
Holding
4,515
New
888
Increased
1,264
Reduced
882
Closed
1,360

Sector Composition

Rank Sector Weight
1 Financials 4.56%
2 Industrials 3.56%
3 Consumer Discretionary 3.21%
4 Technology 3.1%
5 Healthcare 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FHK
2701
DELISTED
First Trust Hong Kong AlphaDEX Fund
FHK
$2K ﹤0.01%
82
AXAS
2702
DELISTED
Abraxas Petroleum Corp
AXAS
$2K ﹤0.01%
632
-226
-26% -$1.02K
BFYT
2703
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$2K ﹤0.01%
+106
New +$2.52K
TUES
2704
DELISTED
Tuesday Morning Corp
TUES
$2K ﹤0.01%
4,169
-4,740
-53% -$6.78K
LBY
2705
DELISTED
Libbey, Inc.
LBY
$2K ﹤0.01%
3,803
-2,040
-35% -$2.49K
WEBK
2706
DELISTED
Wellesley Bancorp, Inc.
WEBK
$2K ﹤0.01%
82
-113
-58% -$4.28K
ASNA
2707
DELISTED
Ascena Retail Group, Inc.
ASNA
$2K ﹤0.01%
1,589
-389
-20% -$1.67K
MACK
2708
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2K ﹤0.01%
773
-1,760
-69% -$5.15K
RUSL
2709
DELISTED
Direxion Daily Russia Bull 2X Shares
RUSL
$2K ﹤0.01%
172
+108
+169% +$5.57K
BSCK
2710
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
$2K ﹤0.01%
+100
New +$2.12K
AMNB
2711
DELISTED
American National Bankshares Inc
AMNB
$2K ﹤0.01%
+88
New +$2.86K
BKSC
2712
DELISTED
Bank of South Carolina
BKSC
$2K ﹤0.01%
125
-404
-76% -$7.03K
AAME icon
2713
Atlantic American Corp
AAME
$29M
$1K ﹤0.01%
619
+500
+420% +$1.1K
ABEO icon
2714
Abeona Therapeutics
ABEO
$361M
$1K ﹤0.01%
+21
New +$1.4K
ACIW icon
2715
ACI Worldwide
ACIW
$5.42B
$1K ﹤0.01%
27
-998
-97% -$31.9K
ACR
2716
ACRES Commercial Realty
ACR
$101M
$1K ﹤0.01%
+168
New +$5.08K
AFBI
2717
DELISTED
Affinity Bancshares
AFBI
$1K ﹤0.01%
+106
New +$1.25K
AKBA icon
2718
Akebia Therapeutics
AKBA
$241M
$1K ﹤0.01%
100
-25
-20% -$195
ALLO icon
2719
Allogene Therapeutics
ALLO
$683M
$1K ﹤0.01%
64
-4,152
-98% -$98.9K
AMED
2720
DELISTED
Amedisys
AMED
$1K ﹤0.01%
6
-34
-85% -$6.05K
AMG icon
2721
Affiliated Managers Group
AMG
$9.7B
$1K ﹤0.01%
21
-2,662
-99% -$199K
APVO icon
2722
Aptevo Therapeutics
APVO
$5.16M
0
ARKR icon
2723
Ark Restaurants
ARKR
$20.2M
$1K ﹤0.01%
48
-323
-87% -$6.17K
ASB icon
2724
Associated Banc-Corp
ASB
$6.07B
$1K ﹤0.01%
80
-105
-57% -$1.88K
EFOR
2725
Everforth Inc
EFOR
$1.37B
$1K ﹤0.01%
37
-20
-35% -$1.13K

Similar funds

Tower Research Capital (TRC)'s Q1 2020 Portfolio in Review

As of Q1 2020, Tower Research Capital (TRC) held 4,515 positions worth $1.64B, up 37% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tower Research Capital (TRC) deployed $940M of net new capital in Q1 2020, opening 888 new positions and adding to 1,264 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 2.5% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $87.2M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2020 buy was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $101M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $87.2M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2020, selling an estimated $19.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 44% of its $1.64B portfolio in Q1 2020.
  • Tower Research Capital (TRC) opened 888 new positions and closed 1,360 in Q1 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.64B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.